Phase 3CompletedAge-related condition
Women's Health Initiative (WHI)
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI) (NIH)
- Conditions
- Bone Diseases; Breast Neoplasms; Cardiovascular Diseases; Colonic Neoplasms; Coronary Disease; Heart Diseases; Myocardial Ischemia; Osteoporosis; Postmenopause
- Interventions
- hormone replacement therapy; estrogens; progestins; estrogen replacement therapy; diet, fat-restricted; calcium; vitamin D; dietary supplements
- Ages
- adults, older adults
- Registry
- NCT00000611
Full record on ClinicalTrials.gov
From the registry
To address cardiovascular disease, cancer, and osteoporosis, the most common causes of death, disability, and impaired quality of life in postmenopausal women. The three major components of the WHI are: a randomized controlled clinical trial of hormone replacement therapy (HRT), dietary modification (DM), and calcium/vitamin D supplementation (CaD); an observational study (OS); and a community prevention study (CPS). On October 1, 1997, administration of the WHI was transferred to the NHLBI where it is conducted as a consortium effort led by the NHLBI in cooperation with the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), the National Cancer Institute (NCI), and the National Institute on Aging (NIA).
History
Last registry update
Primary completion
Registered
Papers citing this trial
- Hormone trials found no clear liver cancer effect in women
British journal of cancer
- Serum-based biomarker development for dietary macronutrient densities and their association with breast and colorectal cancer risk in a cohort of postmenopausal females
The American journal of clinical nutrition
- Diet composition linked to disease risk after menopause
The American journal of clinical nutrition
- Low-fat dietary pattern and dietary advanced glycation end-products intake: a secondary analysis of the Women's Health Initiative randomized trial
British journal of cancer
- Influence of Cardiometabolic Status on Cardiovascular Effects of Oral Menopausal Hormone Therapy
Obstetrics and gynecology
- DXA-Derived Abdominal Adiposity and Obesity-Related Cancer Risk Among Postmenopausal Women in the Women's Health Initiative
Obesity (Silver Spring, Md.)
- Greater adherence to healthful dietary patterns is associated with lower insomnia risk in the Women's Health Initiative Observational Study
Sleep
- Clonal Hematopoiesis and Cardiovascular Outcomes in Older Women
Journal of the American College of Cardiology
In the news
ResearchMedical Xpress (opens Medical Xpress in a new tab)
Modern menopausal hormone therapy shows no increased cardiovascular risk in over 52,000 women
The observational study followed Israeli women ages 45–59 without prior cardiovascular disease for 12 years on average; researchers also report similar premature mortality ahead of AHA Scientific Sessions 2026.
